Hageman factor (factor XII) has a key role in activation of intrinsic coagulation system gauged by activated partial thromboplastin time (aPPT).
Introduction
Hageman factor (factor XII) deficiency is a congenital condition inherited in large majority as autosomal recessive condition. It belongs to the vast group of kinins [1, 2] . Factor XII is important in initiating activation of intrinsic coagulation pathway. Surprisingly it is very rarely if at all associated with bleeding diathesis that too is very mild like epistaxis or skin abrasions. But contrary and confusingly factor XII deficiency is more often associated with thromboembolic complications which are sometimes life threatening [3, 4] . The condition is often incidentally discovered during coagulation screening having isolated prolonged activated partial thromboplastin time (aPTT) or during an unexplained coagulopathy. Association of arterial and venous thromboembolic events has been debated in the literature leading to myocardial infarction and life-threatening pulmonary embolism [4, 5] . A high index of suspicion is kept in individuals, known to have factor XII deficiency, presenting with thromboembolic events spontaneously or more so under provocation as in the subject patient.
Early diagnosis based on unexplained isolated prolonged PTT and prompt intervention with anticoagulation is lifesaving in acute myocardial infarction or massive or sub-massive pulmonary embolism [6] .
Patient and observation
A Saudi female age 29, presented to accident and emergency room (A&E) of our hospital with sudden severe breathlessness and chest pain. She has been ambulant and asymptomatic, discharged recently from our hospital three weeks ago after an uneventful caesarean section delivery being primigravida.
History: she was in obvious respiratory distress, tachypneic and tachycardiac having desaturation at room air under resting conditions. Admitting diagnosis was pulmonary embolism until proved otherwise.
She has been ambulant and had no past history of significance being non-smoker, no history of taking any medications. She denied family history of any blood disorders. Final diagnosis: sub-massive pulmonary embolism, hypoxemic respiratory failure associated with factor XII (Hageman Factor) deficiency.
Management
Admitted to adult intensive care unit (AICU) for close monitoring: 1)
Oxygen via face mask 6 -8litres/min, targeting oxygen saturation above 92%; 2) Anticoagulation with injection clexane 60mg SC Q12Hrs 5 days, then after she was reported factor XII deficient, was started on oral tablet warfarin with therapeutic INR target ranged 2-3. Once INR value above 2 was achieved on warfarin, injection clexane was discontinued; 3) Intravenous fluids normal saline 50ml/hr; 4) Normal diet; 5) Tablet Paracetamol 1gm P.O Q8Hrs.
Course in the hospital
She remained hemodynamically stable, and responded well to management, chest pain subsided within 24 hours of admission, gradually her supplementary oxygen requirement declined and after one week of treatment she was able to maintain acceptable oxygen 
Discussion
In the intrinsic coagulation cascade, factor XII acts as an initiating step orchestrating enzymatic conversion of factor XI to activated factor Xia [7, 8] . Although majority is autosomal recessive as a result of spontaneous mutation, but autosomal dominant inheritance is also reported in the literature. This initial step is followed by thrombin stabilization, release of bradykinin and local inflammatory reaction [9, 10] . Causes of isolated elevated aPPT (activated partial thromboplastin time) include use of unfractionated-heparin, antiphospholipid syndrome, Von Willebrand varients, and deficiency of IX, XI, XII factors [11] . A mixing study and coagulation factor assay is contemplated to confirm the diagnosis. In vitro prolongation of aPPT may not represent increased risk of coagulopathy in vivo, because it is masked by other coagulation factors. Immunoassay is used directly to estimate the levels of factor XII [12] . No other coagulopathy was reported in this patient. The subject patient did not predate any symptoms related to factor XII deficiency, until her presentation with sudden chest pain and breathlessness due to sub-massive pulmonary embolism. Whereas both arterial as well as venous thromboembolic complications has been reported, though rarely, some authors have reported increased risk of bleeding [13] . On the other hand clinical use of heparins may catalyze activation of factor XII, thus prolonging aPPT. A prolonged aPPT in vitro has no relevance to clinically observed in vivo thromboembolic complications. According to the waterfall cascade hypothesis of coagulation, activation of intrinsic pathways is dependent on the presence of factor XII [14] . Paradoxically deficiency of factor XII leads to higher propensity for pro-coagulation rather than manifesting as coagulopathy. This paradoxical manifestations leads to increased number of acute events like myocardial infarction, miscarriages, new stroke or extension of strokes and pulmonary embolism in apparently healthy young patients as of our patient. A bleeding diathesis in the form of chronic subdural hematoma is suggested due to increased vascular permeability rather than coagulopathy [15] . An acquired factor XII deficiency has been reported as well, in patients having liver transplants [16] .
Classification of pulmonary embolism
Our patient did not report any pre-existing symptoms or history of any coagulopathy or acute event in the past. She was ambulant and asymptomatic being hospitalized and discharged, 3 weeks ago after an uneventful caesarian section as a primigravida. Diagnosed having sub-massive pulmonary embolism and respiratory failure associated with factor XII deficiency presentation with sudden breathlessness and chest pain. She was initially treated with low molecular weight heparin and subsequently replaced with oral warfarin.
Conclusion
An isolated prolonged aPTT in a patient having thromboembolic event,
is a pointer to factor XII deficiency as a rare harbinger of life threatening complications as in our patient. Due to the rarity of factor XII deficiency, and variation in its clinical presentations, other possible causes under the clinical circumstances (provocating and nonprovocating) must be ruled out before definitely associating them with inherited coagulopathy. Transmission of autosomal recessive disorders, which put the pregnancy at risk, could be prevented by avoiding consanguineous marriages, necessitating counseling and education. Question remains whether such patients be offered
